Aller au contenu principal
Profil bibliographique

Stefanie K. Gräfe

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

32Publications signalées
1073Citations signalées
4Affiliations récentes

Les institutions déclarées

Les domaines associés

COVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsSARS-CoV-2 and COVID-19 ResearchAntifungal resistance and susceptibilityAcute Myeloid Leukemia Research

Les publications récentes

Accès ouvert 2025 article OpenAlex

Pathology-oriented multiplexing enables integrative disease mapping

Malte B. Kuehl, Yusuke Okabayashi, Milagros N. Wong, Lukas Gernhold et autres

, the integration of biological layers (that is, cell structure, subcellular domains and signalling activity) remains challenging. This is due to limitations in the compositions of antibody panels and image resolution, which together restrict the scope of image analysis. Here we present …

de, dk, jp, ch, au, fr, us (code pays fourni par la source)

24 citations Nature
Accès ouvert 2025 article OpenAlex

Health economic burden of refractory and recurrent Clostridioides difficile infection in the inpatient setting of the German healthcare system – the IBIS Study

Sebastian Marcel Wingen-Heimann, Asad Ullah, Marta Rebeca Cruz Aguilar, Stefanie K. Gräfe et autres

BACKGROUND: Clostridioides difficile infections (CDIs) remain a prevalent and costly healthcare challenge, particularly affecting elderly, comorbid patients. Evidence on the health economic burden of CDI in Germany, particularly in refractory and recurrent patients is limited. METHODS: The IBIS study was a non-interventional …

de (code pays fourni par la source)

2 citations Journal of Hospital Infection
Accès ouvert 2024 article OpenAlex

Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: EPICOVIDEHA ‐ EPIFLUEHA Report

Jon Salmanton‐García, Francesco Marchesi, Milan Navrátil, Klára Piukovics et autres

Community-acquired respiratory viral infections (CARV) significantly impact patients with hematological malignancies (HM), leading to high morbidity and mortality. However, large-scale, real-world data on CARV in these patients is limited. This study analyzed data from the EPICOVIDEHA-EPIFLUEHA registry, focusing on patients with HM …

de, it, cz, hu, nl, es, pl, at, gr, tr, be, sk, ca, by, fr, Égypte, hr, ru, mk, sa, us, gb, dk (code pays fourni par la source)

15 citations American Journal of Hematology
Accès ouvert 2024 article OpenAlex

Comparative effectiveness of vancomycin and metronidazole on event-free survival after initial infection in patients with Clostridioides difficile—a German multicentre cohort study

Katharina Giesbrecht, Rebeca Cruz Aguilar, Stefanie K. Gräfe, Klaus‐Peter Hunfeld et autres

OBJECTIVES: The objective of this study is to examine the comparative effectiveness of vancomycin and metronidazole in a confirmatory analysis of event-free survival (EFS) after initial infection in patients with Clostridioides difficile from a German multicentre cohort study. METHODS: The IBIS multicentre …

de (code pays fourni par la source)

5 citations Clinical Microbiology and Infection
2024 article OpenAlex

Apoptotic cell identity induces distinct functional responses to IL-4 in efferocytic macrophages

Imke Liebold, Amirah Al Jawazneh, Christian Casar, Clarissa Lanzloth et autres

Macrophages are functionally heterogeneous cells essential for apoptotic cell clearance. Apoptotic cells are defined by homogeneous characteristics, ignoring their original cell lineage identity. We found that in an interleukin-4 (IL-4)-enriched environment, the sensing of apoptotic neutrophils by macrophages triggered their tissue remodeling …

de, dk, us, nl (code pays fourni par la source)

92 citations Science
Accès ouvert 2024 article OpenAlex

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

Jon Salmanton‐García, Francesco Marchesi, Francesca Farina, Barbora Weinbergerová et autres

Background: The COVID-19 pandemic heightened risks for individuals with hematological malignancies due to compromised immune systems, leading to more severe outcomes and increased mortality. While interventions like vaccines, targeted antivirals, and monoclonal antibodies have been effective for the general population, their benefits …

de, it, cz, es, dk, pt, nl, Égypte, sa, fr, hr, br, hu, se, be, tr, pk, gb, at, ar, mk, pl, ru, by, qa, us, gr (code pays fourni par la source)

34 citations EClinicalMedicine
Accès ouvert 2024 article OpenAlex

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

Tobias Lahmer, Jon Salmanton‐García, Francesco Marchesi, Shaimaa El‐Ashwah et autres

The risk for a severe coronavirus disease 2019 (COVID-19) with need for an intensive care unit (ICU) admission in a non-immunocompromised vaccinated population dropped from 5% at the beginning of the pandemic to at least 0.2% and is still decreasing since the …

de, it, Égypte, br, fr, hr, rs, cz, tr, be, nl, dk, es, hu, se, pt, at, qa, ar, gb, pl, us, gr, pk, mk (code pays fourni par la source)

10 citations Infection
Accès ouvert 2023 article OpenAlex

The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey

Shaimaa El‐Ashwah, Jon Salmanton‐García, Federico Itri, Pavel P. Zak et autres

Since the beginning of the COVID-19 pandemic, there has been an overall improvement in patient mortality. However, haematological malignancy patients continue to experience significant impacts from COVID-19, including high rates of hospitalization, intensive care unit (ICU) admissions, and mortality. In comparison to …

Égypte, de, nl, it, cz, qa, pt, br, fr, pk, es, ar, be, dk, id, gb, tr, se, om (code pays fourni par la source)

10 citations Leukemia & lymphoma/Leukemia and lymphoma
Accès ouvert 2023 article OpenAlex

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

Giuseppe Rossi, Jon Salmanton‐García, Chiara M. Cattaneo, Francesco Marchesi et autres

OBJECTIVES: Elderly patients with hematologic malignancies face the highest risk of severe COVID-19 outcomes. The infection's impact on different age groups remains unstudied in detail. METHODS: We analyzed elderly patients (age groups: 65-70, 71-75, 76-80, and >80 years old) with hematologic malignancies …

it, de, es, dk, pt, fr, cz, hr, nl, gb, be, br, rs, se, us, hu, by, Égypte, tr, at, gr, ar, pl (code pays fourni par la source)

16 citations International Journal of Infectious Diseases
Accès ouvert 2023 article OpenAlex

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

Jon Salmanton‐García, Francesco Marchesi, Philipp A. Koehler, Barbora Weinbergerová et autres

INTRODUCTION: Molnupiravir and nirmatrelvir/ritonavir are antivirals used to prevent progression to severe SARS-CoV-2 infections and decrease hospitalisation and mortality rates. Nirmatrelvir/ritonavir was authorised in Europe in December 2021, whereas molnupiravir is not yet licensed in Europe as of February 2022. Molnupiravir may …

de, it, cz, rs, es, be, pl, fr, at, tr, gr, se, dk (code pays fourni par la source)

18 citations International Journal of Antimicrobial Agents
Accès ouvert 2023 article OpenAlex

P1521: IMPROVED CLINICAL OUTCOME OF COVID-19 IN HAEMATOLOGIC MALIGNANCY PATIENTS RECEIVING A FOURTH DOSE OF ANTI-SARS-COV-2 VACCINE: AN EPICOVIDEHA REPORT

Jon Salmanton‐García, Francesco Marchesi, Andreas Birkedal Glenthøj, Yavuz Memis Bilgin et autres

Topic: 30. Infections in hematology (incl. supportive care/therapy) Background: There is a lack of consolidated data has resulted in a general skepticism on anti-SARS-CoV-2 fourth dose efficacy. As a consequence, only few individuals received a fourth dose, despite several data supports the …

de, it, dk, nl, be, es, fr, at, gb, tr, hu, cl (code pays fourni par la source)

0 citations HemaSphere

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.